Search
Search Results
##search.searchResults.foundPlural##
-
ASSESSMENT OF CONGENITAL NEUTROPENIA IN CHILDREN: COMMON CLINICAL SCENERIES AND CLUES FOR MANAGEMENT Assessment of congenital neutropenia in children
1875PDF: 1067HTML: 577 -
BLINATUMOMAB IN THE THERAPY OF ACUTE B-LYMPHOID LEUKEMIA BLINATUMOMAB and ALL
1554PDF: 1045HTML: 102 -
TUBERCULOSIS IN HEMATOPOIETIC STEM CELL TRANSPLANT PATIENTS.
2573PDF: 916HTML: 3583 -
How we manage invasive fungal disease in acute myeloid leukemia patients with Glucose 6 Dehydrogenase deficiency
1784PDF: 882HTML: 935Referring article: 729 -
CANDIDEMIA IN PATIENTS WITH ACUTE LEUKEMIA: ANALYSIS OF SEVEN YEARS’ EXPERIENCE AT A SINGLE CENTER IN CHINA Candidemia in acute Leukemia
1648PDF: 913HTML: 212 -
The diagnostic sensitivity of beta-D-glucan assay in patients with chronic disseminated candidiasis
1259PDF: 1059PDF: 853HTML: 149 -
SOCIOECONOMIC STATUS IS GLOBALLY A PROGNOSTIC FACTOR FOR OVERALL SURVIVAL OF MULTIPLE MYELOMA PATIENTS; SYNTHESIS OF STUDIES AND REVIEW OF THE LITERATURE SES as prognostic factor for myeloma survival
1969PDF: 785HTML: 198 -
Cytomorphology of Chimeric Antigen Receptor T-Cells (CAR-T)
1126PDF: 464HTML: 199 -
Status Epilepticus Due to Severe HHV-6 Encephalitis in an Allogeneic Stem Cell Transplant Recipient
1128PDF: 803HTML: 2165Figue 1: 163 -
TREATMENT OF LOW-BLAST COUNT AML USING HYPOMETHYLATING AGENTS
4231PDF: 1709HTML: 1097 -
IS IT POSSIBLE TO PREDICT TUMOR PROGRESSION THROUGH GENOMIC CHARACTERIZATION OF MONOCLONAL GAMMOPATHY AND SMOLDERING MULTIPLE MYELOMA? MONOCLONAL GAMMOPATHY AND SMOLDERING MULTIPLE MYELOMA
2498PDF: 1103HTML: 124 -
Antivirals and monoclonal antibody combination therapy in haematological patients in the omicron era Antiviral and monoclonal Antibodies in Haematological Patients in the omicron era
1219PDF: 904HTML: 83 -
NEW STRATEGIES FOR STEM CELL MOBILIZATION
2345PDF: 827HTML: 2440 -
COMPARISON OF INFECTIOUS COMPLICATIONS IN PATIENTS RECEIVING HIGH-DOSE CYCLOPHOSPHAMIDE AS GVHD AFTER TRANSPLANTATION FROM A 9/10 HLA-MATCHED UNRELATED DONOR WITH STANDARD GVHD PROPHYLAXIS AFTER TRANSPLANT FROM A FULL MATCHING DONOR Infection With PTCy Versus Standard GvHD Prophylaxis
1333PDF: 1273HTML: 81 -
VIRAL HEPATITIS A TO E IN SOUTH MEDITERRANEAN COUNTRIES
1207PDF: 635HTML: 7711 -
HEMATOPOIETIC STEM CELL TRNSPLANTATION IN THALASSEMIA AND RELATED DISORDERS
1365PDF: 478HTML: 3943 -
CMV IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
4728PDF: 1725HTML: 2690Untitled: 197 -
RECENT ADVANCES IN THE 5Q- SYNDROME
2706PDF: 1765HTML: 3640Pellagatti Fig 1: 194Pellagatti Fig. 2: 193 -
Guest Editor: Pellegrino Musto BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA: APPROPRIATE SELECTION OF PATIENTS AND SEQUENCING BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA
1466PDF: 1156HTML: 172







